Literature DB >> 31168735

Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.

Ju Nyeong Park1, Susan G Sherman2, Saba Rouhani2, Kenneth B Morales2, Michelle McKenzie3, Sean T Allen2, Brandon D L Marshall4, Traci C Green4,5.   

Abstract

Safe consumption spaces (SCS) are evidence-based interventions that reduce drug-related morbidity and mortality operating in many countries. However, SCS are yet to be widely implemented in the USA despite the escalating overdose epidemic. The aim of this multi-city study was to identify the factors associated with willingness to use a SCS among people who use drugs (PWUD) in Baltimore, Providence, and Boston, stratified by injection drug use status. Our secondary aim was to characterize the anticipated barriers to accessing SCS if they were to be implemented in these cities. PWUD were invited to complete a cross-sectional survey in 2017. The analysis was restricted to 326 opioid users (i.e., heroin, fentanyl, and non-medical opioid pill use). The majority (77%) of participants expressed willingness to use a SCS (Baltimore, 78%; Providence, 68%; Boston. 84%). Most respondents were male (59%), older than 35 years (76%), non-white (64%), relied on public/semi-public settings to inject (60%), had a history of overdose (64%), and recently suspected fentanyl contamination of their drugs (73%). A quarter (26%) preferred drugs containing fentanyl. Among injectors, female gender, racial minority status, suspicion of drugs containing fentanyl, and drug use in public/semi-public settings were associated with higher willingness to use a SCS; prior arrest was associated with lower willingness. Among non-injectors, racial minority status, preference for fentanyl, and drug use in public/semi-public settings were associated with higher willingness, whereas recent overdose held a negative association. The most commonly anticipated barriers to accessing a SCS in the future were concerns around arrest (38%), privacy (34%), confidentiality/trust/safety (25%), and cost/time/transportation (16%). These data provide evidence of high SCS acceptability among high-risk PWUD in the USA, including those who prefer street fentanyl. As SCS are implemented in the USA, targeted engagement efforts may be required to reach individuals exposed to the criminal justice system.

Entities:  

Keywords:  Addiction; Overdose prevention; Substance use; Supervised injection

Year:  2019        PMID: 31168735      PMCID: PMC6565790          DOI: 10.1007/s11524-019-00365-1

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  36 in total

Review 1.  Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.

Authors:  Scott Burris; Kim M Blankenship; Martin Donoghoe; Susan Sherman; Jon S Vernick; Patricia Case; Zita Lazzarini; Stephen Koester
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

2.  Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.

Authors:  Evan Wood; Thomas Kerr; Will Small; Kathy Li; David C Marsh; Julio S G Montaner; Mark W Tyndall
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

3.  The social structural production of HIV risk among injecting drug users.

Authors:  Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee
Journal:  Soc Sci Med       Date:  2005-03-19       Impact factor: 4.634

4.  Release from prison--a high risk of death for former inmates.

Authors:  Ingrid A Binswanger; Marc F Stern; Richard A Deyo; Patrick J Heagerty; Allen Cheadle; Joann G Elmore; Thomas D Koepsell
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

5.  Changes in injecting practices associated with the use of a medically supervised safer injection facility.

Authors:  Jo-Anne Stoltz; Evan Wood; Will Small; Kathy Li; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Public Health (Oxf)       Date:  2007-01-17       Impact factor: 2.341

6.  Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Authors:  Brandon D L Marshall; M-J Milloy; Evan Wood; Julio S G Montaner; Thomas Kerr
Journal:  Lancet       Date:  2011-04-15       Impact factor: 79.321

7.  The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs.

Authors:  Leo Beletsky; Lauretta E Grau; Edward White; Sarah Bowman; Robert Heimer
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

8.  A multi-site comparison of supported housing for chronically homeless adults: "Housing first" versus "residential treatment first"

Authors:  Jack Tsai; Alvin S Mares; Robert A Rosenheck
Journal:  Psychol Serv       Date:  2010

9.  Acceptability of a safer injection facility among injection drug users in San Francisco.

Authors:  Alex H Kral; Lynn Wenger; Lisa Carpenter; Evan Wood; Thomas Kerr; Philippe Bourgois
Journal:  Drug Alcohol Depend       Date:  2010-03-19       Impact factor: 4.492

10.  Injection drug use cessation and use of North America's first medically supervised safer injecting facility.

Authors:  Kora DeBeck; Thomas Kerr; Lorna Bird; Ruth Zhang; David Marsh; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2010-08-30       Impact factor: 4.492

View more
  13 in total

1.  Expanding a Comprehensive Strategy for Overdose Prevention in the USA.

Authors:  David Vlahov
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

2.  "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.

Authors:  Sarah S Shin; Kate LaForge; Erin Stack; Justine Pope; Gillian Leichtling; Jessica E Larsen; Judith M Leahy; Andrew Seaman; Daniel Hoover; Laura Chisholm; Christopher Blazes; Robin Baker; Mikaela Byers; Katie Branson; P Todd Korthuis
Journal:  Harm Reduct J       Date:  2022-07-11

3.  Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007-2019.

Authors:  Tarlise Townsend; David Kline; Ariadne Rivera-Aguirre; Amanda M Bunting; Pia M Mauro; Brandon D L Marshall; Silvia S Martins; Magdalena Cerdá
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

4.  Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time.

Authors:  Keri N Althoff; Kathryn M Leifheit; Ju Nyeong Park; Aruna Chandran; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2020-09-25       Impact factor: 4.492

5.  Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.

Authors:  Ju Nyeong Park; Saba Rouhani; Leo Beletsky; Louise Vincent; Brendan Saloner; Susan G Sherman
Journal:  Milbank Q       Date:  2020-08-18       Impact factor: 4.911

6.  Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.

Authors:  Allison O'Rourke; Rebecca Hamilton White; Ju Nyeong Park; Kayla Rodriguez; Michael E Kilkenny; Susan G Sherman; Sean T Allen
Journal:  Harm Reduct J       Date:  2019-08-31

Review 7.  New and Emerging Opioid Overdose Risk Factors.

Authors:  Ralph Foglia; Anna Kline; Nina A Cooperman
Journal:  Curr Addict Rep       Date:  2021-04-22

8.  Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis.

Authors:  Ju Nyeong Park; Kristin E Schneider; David Fowler; Susan G Sherman; Ramin Mojtabai; Paul S Nestadt
Journal:  J Addict Med       Date:  2022 Jan-Feb 01       Impact factor: 3.702

9.  High willingness to use overdose prevention sites among female sex workers in Baltimore, Maryland.

Authors:  Saba Rouhani; Rebecca Hamilton White; Ju Nyeong Park; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2020-05-11       Impact factor: 4.852

10.  Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs.

Authors:  Shannon R Kenney; Bradley J Anderson; Genie L Bailey; Debra S Herman; Micah T Conti; Michael D Stein
Journal:  Am J Addict       Date:  2020-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.